ASCO 2026 Lung Cancer — Influencer Networks

This visualization is compiled by the KOL Pulse research team from curated lung-cancer tweets tagged to ASCO 2026 and enriched with engagement identities via the X API. Every account is classified against the KOL Pulse registry (verified US physicians are cross-referenced with CMS Open Payments). No accounts are fabricated; all tweet counts and impressions are as reported by X.

What does the ASCO 2026 lung cancer influencer network show?

It maps the retweet, quote, and mention relationships among 1896 X/Twitter accounts discussing lung cancer research at ASCO 2026 Annual Meeting. Node size reflects impressions; ring color reflects account type (verified US physician, international MD, media/org, amplifier, or mentioned). 229 accounts authored original lung-cancer tweets.

How do I filter the network by clinical trial?

Use the Lung Trial dropdown in the left control panel. Selecting a trial (for example WU-KONG28, HARMONi-6, LIBRETTO-432, CROWN, or ROSETTA Lung-02) shows only the accounts and edges tied to that trial. An account is tied to a trial when it authored a tweet tagged to that trial or engaged a KOL who did. Choose 'All lung trials' to return to the full network.

How are US physicians verified?

Accounts classified as US physicians are cross-referenced against the CMS Open Payments dataset and the KOL Pulse classified registry. They render with a gold ring and a US badge.

Which lung trials are represented?

The filterable trials (each tied to at least three curated tweets) are HARMONi-6, LIBRETTO-432, CROWN, BEAMION-Lung-1, WU-KONG28, ADAURA, IMforte, DeLLphi-304, CHRYSALIS-2, OptiTROP-Lung05, LORIN, TRITON, ALCHEMIST, ALKOVE-1, AcceleRET-Lung, ROSETTA Lung-02, SUNRAY-01.

What is the data source?

KOL Pulse curated 1406 lung-cancer tweets tagged to ASCO 2026 and enriched them with engagement identities (who retweeted and quoted each post) via the X API. Accounts were then classified using the KOL Pulse registry.